Related Articles
Efficacy analysis of immunotherapy‑based combinations for patients with EGFR‑mutant advanced non‑small cell lung cancer after TKI failure
First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status
Radium‑223 in patients with metastatic castration‑resistant prostate cancer: Efficacy and safety in clinical practice
Paclitaxel and carboplatin chemotherapy after platinum‑based chemotherapy and pembrolizumab for metastatic urothelial carcinoma
Clinical use of molecular targeted agents for primary small bowel adenocarcinoma: A multicenter retrospective cohort study by the Osaka Gut Forum